digitalstudios2026-06-03T09:39:45+00:00Ingenix Raises €13m From Sofinnova Partners-Led Syndicate to Scale Modality Fusion, a Novel Architecture for Drug Development
digitalstudios2026-06-03T09:33:19+00:00JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)
digitalstudios2026-06-03T09:25:10+00:00Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care